← Back to Search

Soft Contact Lens

senofilcon A/balafilcon A for Refractive Errors

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 4 weeks of lens wear
Awards & highlights
No Placebo-Only Group

Summary

This study seeks to evaluate the clinical and subjective performance of two established soft contact lenses.

Eligible Conditions
  • Refractive Errors
  • Near-sightedness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 4 weeks of lens wear
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 4 weeks of lens wear for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient-reported Comfort at at the Manufacturer's Recommended Lens Replacement Timeframe of 2-weeks (Senofilcon A) or 4-weeks (Balafilcon A).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: senofilcon A/balafilcon AActive Control2 Interventions
senofilcon A silicone hydrogel contact lens worn during first 4-week period, balafilcon A silicone hydrogel contact lens worn during the second 4-week period. Senofilcon A lenses worn daily on a 2-week replacement schedule; balafilcon A lenses worn daily on a 4-week replacement schedule. Lens replacement conducted in-office in a masked process.
Group II: balafilcon A/senofilcon AActive Control2 Interventions
balafilcon A silicone hydrogel contact lens worn worn during first 4-week period, senofilcon A silicone hydrogel contact lens worn during the second 4-week period. Senofilcon A lenses worn daily on a 2-week replacement schedule; balafilcon A lenses worn daily on a 4-week replacement schedule. Lens replacement conducted in-office in a masked process.

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
219 Previous Clinical Trials
25,751 Total Patients Enrolled
22 Trials studying Refractive Errors
1,996 Patients Enrolled for Refractive Errors
~2 spots leftby Nov 2025